What to watch in the day ahead
It's the first day of sales for Sony's PlayStation 4 interactive gaming console. Sony is hoping that PS4 will help the Japanese electronics maker return to profit even as it gears up for a console war with Microsoft, maker of the rival Xbox, this holiday-season. While Sony's counting on the console to kick-start a revival, the broader video games industry has seen sluggish sales in recent years, hurt by the rise of free games on mobile devices and social networks like Facebook.
GE holds an meeting for investors and analysts focused on its GE Capital business, to which the conglomerate is seeking to reduce its exposure as it increasingly favors its industrial manufacturing divisions. Wall Street will be eager to learn about GE's plans for shrinking GE Capital, including potential sales or spin-offs, and how the company plans to position the financing business.
The Federal Reserve releases its report on U.S. industrial production, which likely rose modestly in October, held back by decline in utilities and mining output.
The FDA is expected to post its review of BioMarin Pharmaceutical's drug Vimizim for the treatment of a rare lysosomal storage disorder known as Morquio A Syndrome. The report comes ahead of a meeting next week of an FDA advisory panel which will recommend whether the drug should be approved.
Zulily, a 'flash sales' company founded by former Blue Nile executives Mark Vadon and Darrell Cavens, is expected to raise up to $238 million in an initial public offering of its shares which comes less than a year after it raised $85 million in a deal led by venture capital firm Andreessen Horowitz that valued it at about $1 billion. Flash sales companies sell merchandise in short-term, heavily discounted events each day.